nach oben

Der Nervenarzt

Erschienen in:

01.12.2014 | Leitthema

Ernährung und Nahrungsergänzungsmittel bei neurologischen Erkrankungen

verfasst von: Prof. Dr. F. Erbguth, H. Himmerich

Erschienen in: Der Nervenarzt | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

„Gesunde“ Ernährungsweisen und Nahrungsergänzungsmittel werden zur Prävention und Krankheitsmodifikation bei vaskulären, entzündlichen, degenerativen und anderen neurologischen Erkrankungen empfohlen und propagiert. Neben einer Vielzahl von Assoziationsstudien liegen allerdings nur wenige Interventionsstudien zu einzelnen Ernährungsweisen vor. Aktuell konnte für eine mediterrane Diät mit viel Olivenöl und Nüssen eine schlaganfallpräventive Wirkung belegt werden; eine ketogene Diät senkt die Anfallsfrequenz bei Epilepsie. Für Riboflavin, Magnesium und Koenzym Q10 konnten Hinweise auf eine Wirksamkeit bei der Migräne erbracht werden. Kreatin kann die Muskelkraft bei Muskeldystrophien und Myositiden verbessern. Für alle anderen neurologischen Erkrankungen existieren zurzeit keine ausreichenden Evidenzen, um eine der vielen Nahrungsergänzungsmittel wie Vitamine, ω-3-Fettsäuren und andere Substanzen zur Prävention oder positiven Krankheitsbeeinflussung empfehlen zu können. In der Übersicht werden die vorliegenden Daten zur Rolle der Ernährung und Nahrungsergänzung bei neurologischen Erkrankungen kritisch gewürdigt.

Alcalay RN, Gu Y, Mejia-Santana H (2012) The association between Mediterranean diet adherence and Parkinson’s disease. Mov Disord 27:771–774PubMedCentralPubMedCrossRef

Ascherio A, Munger KL, White R et al (2014) Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 71:306–314PubMedCrossRef

Baker MG, Kvalsvig A, Zhang J et al (2012) Declining Guillain-Barré syndrome after campylobacteriosis control, New Zealand, 1988–2010. Emerg Infect Dis 18:226–233PubMedCentralPubMedCrossRef

Bjelakovic G, Nikolova D, Gluud LL et al (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297:842–857PubMedCrossRef

Brochet B, Guinot P, Orgogozo JM et al (1995) Double-blind, placebo controlled, multicentre study of ginkgolide B in treatment of acute exacerbations for multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis. J Neurol Neurosurg Psychiatry 58:360–362PubMedCentralPubMedCrossRef

Chen GC, Lu DB, Pang Z et al (2013) Vitamin C intake, circulating Vitamin C and risk of stroke: a meta-analysis of prospective studies. J Am Heart Assoc. doi:10.1161/JAHA.113.000329 (Epub)

Clarke R, Halsey J, Lewington S et al (2010) Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 170:1622–1631PubMedCrossRef

Dehlendorff C, Andersen KK, Olsen TS (2014) Body mass index and death by stroke: no obesity paradox. JAMA Neurol. doi:10.1001/jamaneurol.2014.1017

Duley L, Gülmezoglu AM, Henderson-Smart DJ (2003) Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev CD000025

10.

Estruch R, Ros E, Salas-Salvadó J et al (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368:1279–1290PubMedCrossRef

11.

Farinotti M, Vacchi L, Simi S et al (2012) Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev 12. Art. No.: CD004192. doi:10.1002/14651858.CD004192.pub3

12.

Fitzgerald KC, O’Reilly EJ, Falcone GJ et al (2014) Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurol 71:1102–1110PubMedCrossRef

13.

Flicker L, Vasikaran SD, Thomas J et al (2006) Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia. Stroke 37:547–549PubMedCrossRef

14.

Gao X, Chen H, Fung TT et al (2007) Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 86:1486–1494PubMedCentralPubMed

15.

Gardener H, Rundek T, Wright CB et al (2012) Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke 43:1200–1205PubMedCentralPubMedCrossRef

16.

Gonsette RE et al (2010) Boosting endogenous neuroprotection in multiple sclerosis: the Association of Inosine and Interferon β in relapsing – remitting Multiple Sclerosis (ASIIMS) trial. Mult Scler 16:455–462PubMedCrossRef

17.

Hankey GJ (2012) Stroke nutrition and the risk of stroke. Lancet Neurol 11:66–81PubMedCrossRef

18.

Hartley L, Igbinedion E, Holmes J (2013) Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases. Cochrane Database Syst Rev 6:CD009874. doi:10.1002/14651858.CD009874.pub2. ReviewPubMed

19.

He FJ, Nowson CA, MacGregor GA (2006) Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 367:320–326PubMedCrossRef

20.

Hedström AK, Hillert J, Olsson T et al (2013) Smoking and multiple sclerosis susceptibility. Eur J Epidemiol 28:867–874PubMedCentralPubMedCrossRef

21.

Hedström AK, Hillert J, Olsson T et al (2014) Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurol 71:300–305PubMedCrossRef

22.

Hooper DC, Spitsin S, Kean RB et al (1998) Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 95:675–680PubMedCentralPubMedCrossRef

23.

James E, Dobson R, Kuhle J (2013) The effect of Vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis. Mult Scler J 19:1571–1579CrossRef

24.

Kamel F, Goldman SM, Umbach DM (2014) Dietary fat intake, pesticide use, and Parkinson’s disease. Parkinsonism Relat Disord 20:82–87PubMedCrossRef

25.

Kamm CP, El-Koussy M, Humpert S et al (2014) Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial. PLoS One 9 (Epub)

26.

Karam C, Barrett MJ, Imperato T et al (2013) Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis. J Clin Neurosci 20:1550–1553PubMedCrossRef

27.

Kira J, Tobimatsu S, Goto I (1994) Vitamin B12 metabolism and massive-dose methyl Vitamin B12 therapy in Japanese patients with multiple sclerosis. Intern Med 33:82–86PubMedCrossRef

28.

Kley RA, Tarnopolsky MA, Vorgerd M (2013) Creatine for treating muscle disorders. Cochrane Database Syst Rev. doi:10.1002/14651858.CD004760.pub4

29.

Kossoff E, Wang HS (2013) Dietary Therapies for Epilepsy. Biomed J 36:2–8PubMedCrossRef

30.

Kurth T, Moore SC, Gaziano JM et al (2006) Healthy lifestyle and the risk of stroke in women. Arch Intern Med 166:1403–1409PubMedCrossRef

31.

Lamas GA, Bioneau R, Goertz C et al (2013) Oral high-dose multivitamins and minerals after myocardial infarction. A randomized trial. Ann Intern Med 159:797–804PubMedCentralPubMed

32.

Larsson SC (2014) Coffee, tea, and cocoa and risk of stroke. Stroke 45:309–314PubMedCrossRef

33.

Larsson SC, Orsini N (2011) Fish consumption and risk of stroke. A dose-response meta-analysis. Stroke 42:3621–3623PubMedCrossRef

34.

Lee M, Hong KS, Chang SC et al (2010) Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke 41:1205–1212PubMedCentralPubMedCrossRef

35.

Lee SW, Chung SS (2010) A review of the effects of vitamins and other dietary supplements on seizure activity. Epilepsy Behav 18:139–150PubMedCrossRef

36.

Levy RG, Cooper PN, Giri P (2012) Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev. doi:10.1002/14651858.CD001903.pub2

37.

Liu B et al (2012) Serum uric acid levels in patients with multiple sclerosis: a meta-analysis. Neurol Res 34:163–171PubMed

38.

Lovera J, Bagert B, Smoot K et al (2007) Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial. Mult Scler 13:376–385PubMed

39.

Marik PE, Varon J (2009) Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 32:365–372PubMedCrossRef

40.

Markowitz CE et al (2009) The treatment of multiple sclerosis with inosine. J Altern Complement Med 15:619–625PubMedCentralPubMedCrossRef

41.

Micha R, Wallace SK, Mozaffarian D (2010) Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation 121:2271–2283PubMedCentralPubMedCrossRef

42.

Michal Freedman D, Kuncl RW, Weinstein SJ et al (2013) Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14:246–251CrossRef

43.

Michos ED, Carson KA, Schneider AL et al (2014) Vitamin D and subclinical cerebrovascular disease: the atherosclerosis risk in communities brain magnetic resonance imaging study. JAMA Neurol. doi:10.1001/jamaneurol.2014.755

44.

Miyake Y, Sasaki S, Tanaka K et al (2010) Dietary fat intake and risk of Parkinson’s disease: a case-control study in Japan. J Neurol Sci 288:117–122PubMedCrossRef

45.

Mowry EM et al (2010) Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 67:618–624PubMed

46.

Muir SW, Montero-Odasso M (2011) Effect of Vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 59:2291–2300PubMedCrossRef

47.

Orr SL, Venkateswaran S (2014) Nutraceuticals in the prophylaxis of pediatric migraine: evidence-based review and recommendations. Cephalalgia 34:568–583PubMedCrossRef

48.

Osmond C, Kajantie E, Forsén TJ et al (2007) Infant growth and stroke in adult life: the Helsinki birth cohort study. Stroke 38:264–270PubMedCrossRef

49.

Oude Griep LM, Verschuren WM, Kromhout D et al (2011) Colors of fruit and vegetables and 10-year incidence of stroke. Stroke 42:3190–3195CrossRef

50.

Pantzaris MC, Loukaides GN, Ntzani EE (2013) A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial. BMJ Open 3:e002170. doi:10.1136/bmjopen-2012-002170PubMedCentralPubMedCrossRef

51.

Parkinson Study Group (1993) Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med 328:176–183CrossRef

52.

Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I et al (2014) A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol 71:543–552CrossRef

53.

Parkinson Study Group SURE-PD Investigators, Schwarzschild MA, Ascherio A, Beal MF (2014) Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol 71:141–150CrossRef

54.

Postuma RB, Lang AE, Munhoz RP et al (2012) Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology 79:651–658PubMedCentralPubMedCrossRef

55.

Psaltopoulou T, Sergentanis TN, Panagiotakos DB (2013) Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol 74:580–591PubMedCrossRef

56.

Qi H, Li S (2014) Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson’s disease. Geriatr Gerontol Int 14:430–439PubMedCrossRef

57.

Schwarz S, Leweling H, Meinck HM (2005) Alternative und komplementäre Therapien der Multiplen Sklerose. Fortschr Neurol Psychiatr 73:451–462PubMedCrossRef

58.

Seidl SE, Santiago JA, Bilyk H et al (2014) The emerging role of nutrition in Parkinson’s disease. Front Aging Neurosci 6:1–14. doi:10.3389/fnagi.2014.00036CrossRef

59.

Shimazu T, Kuriyama S, Hozawa A et al (2007) Dietary patterns and cardiovascular disease mortality in Japan: a prospective cohort study. Int J Epidemiol 36:600–609PubMedCrossRef

60.

Suzuki M, Yoshioka M, Hashimoto M (2013) Randomized, double-blind, placebo-controlled trial of Vitamin D supplementation in Parkinson disease. Am J Clin Nutr 97:1004–1013PubMedCrossRef

61.

Swank RL, Goodwin J (2003) Review of MS patient survival on a Swank low saturated fat diet. Nutrition 19:161–162PubMedCrossRef

62.

Thakur KT, Probasco JC, Hocker SE et al (2014) Ketogenic diet for adults in super-refractory status epilepticus. Neurology 82:665–670PubMedCrossRef

63.

Torkildsen O, Wergeland S, Bakke S et al (2012) Omega‑3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol 69:1044–1051PubMedCrossRef

64.

Geldern G von, Mowry EM (2014) The influence of nutritional factors on the prognosis of multiple sclerosis. Nat Rev Neurol 8:678–689CrossRef

65.

Wade DT, Young CA, Chaudhuri KR et al (2002) A randomised placebo controlled exploratory study of Vitamin B-12, lofepramine, and l‑phenylalanine (the „Cari Loder regime“) in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 73:246–249PubMedCentralPubMedCrossRef

66.

Wang L, Manson JE, Song Y et al (2010) Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 152:315–323PubMedCrossRef

67.

Weinstock-Guttman B et al (2011) Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. Neuroinflammation 8:127CrossRef

68.

Whitlock G, Lewington S, Sherliker P et al (2009) Body-mass index and cause-specific mortality in 900.000 adults: collaborative analyses of 57 prospective studies. Lancet 373:1083–1096PubMedCrossRef

69.

Wills AM, Hubbard J, Macklin EA et al (2014) Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet 383:2065–2072PubMedCrossRef

70.

Wolfrath SC, Borenstein AR, Schwartz S et al (2006) Use of nutritional supplements in Parkinson’s disease patients. Mov Disord 21:1098–1101PubMedCrossRef

Titel: Ernährung und Nahrungsergänzungsmittel bei neurologischen Erkrankungen
verfasst von: Prof. Dr. F. Erbguth
H. Himmerich
Publikationsdatum: 01.12.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Der Nervenarzt / Ausgabe 12/2014
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI: https://doi.org/10.1007/s00115-013-3975-5

Neu in den Fachgebieten Neurologie und Psychiatrie

23.04.2024 | Demenz | Nachrichten

Springer Medizin

Ernährung und Nahrungsergänzungsmittel bei neurologischen Erkrankungen

Zusammenfassung

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2014

Neuroenhancement

Psychotherapie für alle?

Körperliches Training bei neurologischen und psychischen Erkrankungen

Mitteilungen der Schlaganfallgesellschaft 12/2014

Mitteilungen der DGPPN 12/2014

Ernährung und Nahrungsergänzungsmittel bei psychiatrischen Erkrankungen

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein